0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Autoimmunity in narcolepsy

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Purpose

          Summarize the recent findings in narcolepsy focusing on the environmental and genetic risk factors in disease development.

          Recent findings

          Both genetic and epidemiological evidence point towards an autoimmune mechanism in the destruction of orexin/hypocretin neurons. Recent studies suggest both humoral and cellular immune responses in the disease development.

          Summary

          Narcolepsy is a severe sleep disorder, where neurons producing orexin/hypocretin in the hypothalamus are destroyed. The core symptoms of narcolepsy are debilitating, extreme sleepiness, cataplexy and abnormalities in the structure of sleep. Both genetic and epidemiological evidence point towards an autoimmune mechanism in the destruction of orexin/hypocretin neurons. Importantly, the highest environmental risk is seen with influenza-A (pH1N1) infection and immunization. However, how the cells are destroyed is currently unknown. In this review we summarize the disease symptoms, and focus on the immunological findings in narcolepsy. We also discuss the environmental and genetic risk factors as well as propose a model for disease development.

          Related collections

          Author and article information

          Journal
          9503765
          20595
          Curr Opin Pulm Med
          Curr Opin Pulm Med
          Current opinion in pulmonary medicine
          1070-5287
          1531-6971
          11 October 2017
          November 2017
          01 November 2018
          : 23
          : 6
          : 522-529
          Affiliations
          [1 ]Stanford University School of Medicine, Department of Psychiatry and Behavioral Sciences, Center for Sleep Sciences, Palo Alto, CA 94304, USA
          [2 ]National Institute for Health and Welfare, Public Genomics Unit, Helsinki, Finland
          [3 ]Institute for Molecular Medicine FIMM, University of Helsinki, Helsinki, Finland
          Author notes
          Correspondence to Melodie Bonvalet and Emmanuel Mignot, Stanford University Center for Sleep Sciences, 3165 Porter Drive, Palo Alto, CA 94304, USA; Phone: 1 (650) 725-6517, FAX: 1 (650) 725-4913, mignot@ 123456stanford.edu , bonvaletmelodie@ 123456gmail.com
          Article
          PMC5773260 PMC5773260 5773260 nihpa910370
          10.1097/MCP.0000000000000426
          5773260
          28991006
          0d0de3e1-020e-4173-a1a9-3399eaf8b04d
          History
          Categories
          Article

          autoimmune disease,Sleep disorders,genetics,infectious diseases

          Comments

          Comment on this article